 |
Originally Broadcast:
Tuesday, June 8, 2004
10:00 AM Eastern
This moderated discussion begins with a brief slide review of the topic by the presenter, which is followed by a question and answer session.
|
|
 |
| Dr. Ricardo Costa, MD |
|
|
Read Dr. Costa's Online Summary
|
|
| Listen to the archived on-line audio discussion |
|
Click on the Media Player of your choice to listen to the program: Need a plug-in?
|
|
|
|
| The Multicenter Evaluation of the Everolimus Eluting Stent for Inhibition Neointimal Hyperplasia: Results of the Pooled FUTURE I and II Trials |
| This summary looks at a pooled analysis of the FUTURE I and II data, with angiographic endpoints of in-stent late loss and binary restenosis assessed at 6 months follow-up. |
Presenter:
Ricardo A. Costa, MD
Interventional Cardiologist, Research Fellow
The Cardiovascular Research Foundation
Lenox Hill Heart and Vascular Institute
New York, New York
Moderator:
Jamie B. Conti, MD, FACC
Associate Professor of Medicine
Co-Chair, 2004 Annual Scientific Session Program Committee
University of Florida
Gainesville, FL
|
|
 |
| Supported by an educational grant from: |
|
|
|
|
|
